The Relationship Between Food Deserts, Farmers’ Markets and Food Assistance in Georgia Census Tracts

Background: Due to inadequate resources and limited access to healthy foods, residents of food deserts struggle to maintain a well-balanced, nutritious diet. These factors increase the risk of developing obesity and diet-related chronic diseases. Local farmers’ markets serve as community-level interventions, bringing healthy food to food deserts. Over the past two decades, farmers’ markets have been growing in numbers nationally. The present study explores the relationship between food deserts, placement of farmers’ markets, and availability of food assistance programs in Georgia. Methods: Data are from the 2014 USDA Food Desert Atlas and the USDA Farmers’ Market Directory. Farmers’ market addresses were geocoded in ArcGIS 10.2. Descriptive statistics and spatial visualization were used to explore census tract-level relationships. Results: Of the Georgia census tracts, 20% are food deserts. Of these, 7.2% have a farmers’ market within their boundary, compared to 5.7% of non-food desert tracts. Of these markets, 3.2% accept Famers’ Market Nutrition Program (FMNP) coupons, 9.6% accept Women, Infants, and Children Fruit and Vegetable Checks (WIC-FVC), and 21.6% accept Supplemental Nutrition Assistance Program (SNAP) benefits. Conclusions: Few farmers’ markets in Georgia are located in food deserts, and few accept food assistance programs. Fresh food remains inaccessible to low-income residents in these areas and lack of access to fresh food is associated with dietrelated chronic diseases. To reduce food insecurity, farmers’ markets could accept food assistance program funds. Additional farmers’ markets could be established in food deserts to increase availability of healthy food, reducing the risk of developing obesity and diet-related chronic diseases

The Bolocam Galactic Plane Survey IV: 1.1 and 0.35 mm Dust Continuum Emission in the Galactic Center Region

The Bolocam Galactic Plane Survey (BGPS) data for a six square degree region of the Galactic plane containing the Galactic center is analyzed and compared to infrared and radio continuum data. The BGPS 1.1 mm emission consists of clumps interconnected by a network of fainter filaments surrounding cavities, a few of which are filled with diffuse near-IR emission indicating the presence of warm dust or with radio continuum characteristic of HII regions or supernova remnants. New 350 {\mu}m images of the environments of the two brightest regions, Sgr A and B, are presented. Sgr B2 is the brightest mm-emitting clump in the Central Molecular Zone and may be forming the closest analog to a super star cluster in the Galaxy. The Central Molecular Zone (CMZ) contains the highest concentration of mm and sub-mm emitting dense clumps in the Galaxy. Most 1.1 mm features at positive longitudes are seen in silhouette against the 3.6 to 24 {\mu}m background observed by the Spitzer Space Telescope. However, only a few clumps at negative longitudes are seen in absorption, confirming the hypothesis that positive longitude clumps in the CMZ tend to be on the near-side of the Galactic center, consistent with the suspected orientation of the central bar in our Galaxy. Some 1.1 mm cloud surfaces are seen in emission at 8 {\mu}m, presumably due to polycyclic aromatic hydrocarbons (PAHs). A ~0.2\degree (~30 pc) diameter cavity and infrared bubble between l \approx 0.0\degree and 0.2\degree surrounds the Arches and Quintuplet clusters and Sgr A. The bubble contains several clumpy dust filaments that point toward Sgr A\ast; its potential role in their formation is explored. [abstract truncated]Comment: 76 pages, 22 figures, published in ApJ: http://iopscience.iop.org/0004-637X/721/1/137

The turbulent structure and diurnal growth of the Saharan atmospheric boundary layer

The turbulent structure and growth of the remote Saharan atmospheric boundary layer (ABL) is described with in situ radiosonde and aircraft measurements and a large-eddy simulation model. A month of radiosonde data from June 2011 provides a mean profile of the midday Saharan ABL, which is characterized by a well-mixed convective boundary layer, capped by a small temperature inversion (<1K) and a deep, near-neutral residual layer. The boundary layer depth varies by up to 100% over horizontal distances of a few kilometers due to turbulent processes alone. The distinctive vertical structure also leads to unique boundary layer processes, such as detrainment of the warmest plumes across the weak temperature inversion, which slows down the warming and growth of the convective boundary layer. As the boundary layer grows, overshooting plumes can also entrain freetropospheric air into the residual layer, forming a second entrainment zone that acts to maintain the inversion above the convective boundary layer, thus slowing down boundary layer growth further.Asingle-column model is unable to accurately reproduce the evolution of the Saharan boundary layer, highlighting the difficulty of representing such processes in large-scale models. These boundary layer processes are special to the Sahara, and possibly hot, dry, desert environments in general, and have implications for the large-scale structure of the Saharan heat low. The growth of the boundary layer influences the vertical redistribution of moisture and dust, and the spatial coverage and duration of clouds, with large-scale dynamical and radiative implications

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Advances in the surgical management of the axilla in patients treated with neoadjuvant chemotherapy, especially those with node positive disease at diagnosis, have led to changes in practice and more judicious use of axillary lymph node dissection that may minimize morbidity from surgery. However, there is still significant confusion about how to optimally manage the axilla, resulting in variation among practices. From the viewpoint of drug development, assessment of response to neoadjuvant chemotherapy remains paramount and appropriate assessment of residual disease-the primary endpoint of many drug therapy trials in the neoadjuvant setting-is critical. Therefore decreasing the variability, especially in a multicenter clinical trial setting, and establishing a minimum standard to ensure consistency in clinical trial data, without mandating axillary lymph node dissection, for all patients is necessary. The key elements which include proper staging and identification of nodal involvement at diagnosis, and appropriately targeted management of the axilla at the time of surgical resection are presented. The following protocols have been adopted as standard procedure by the I-SPY2 trial for management of axilla in patients with node positive disease, and present a framework for prospective clinical trials and practice

Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

[This corrects the article DOI: 10.1038/s41523-018-0074-6.]